Patients with moderate-to-severe AD can experience symptoms that disrupt sleep, thus impacting their daily activities and quality of life, said Druhan Howell, MD, a pediatric allergist and ...
William Schpero, PhD, MPhil, MPH, from the Weill Cornell Graduate School of Medicine, explained that new responsibilities for ...
Panelists discuss how GLP-1 therapies show dual metabolic and hepatic benefits, redefining MASH management. Stay ahead of ...
Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...
Panelists discuss how recognizing high-risk patients and linking liver care with metabolic management can reduce both disease ...
Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results